Glen Clova Scientific develops Active Biologic drugs aimed at creating natural antibodies against harmful targets and making high quality treatments for chronic diseases accessible.
peer of
investor of
Metrics
marketPRIVATE
msh_idCOM:GLENCLOVASCIENTIFIC
localegb
websitehttps://glenclovascientific.com/
source_ref031a4d6e-6528-45cc-b6e1-d5d8a4d41d3a
products_or_servicesActive Biologic drugs for chronic disease treatment, drug licensing, and technology licensing.
United Kingdom